Structure and property based design of factor Xa inhibitors: biaryl pyrrolidin-2-ones incorporating basic heterocyclic motifs

Bioorg Med Chem Lett. 2008 Jan 1;18(1):28-33. doi: 10.1016/j.bmcl.2007.11.019. Epub 2007 Nov 13.

Abstract

Structure and property based drug design was exploited in the synthesis of sulfonamidopyrrolidin-2-one-based factor Xa (fXa) inhibitors, incorporating basic biaryl P4 groups, producing highly potent inhibitors with significant anticoagulant activities and encouraging oral pharmacokinetic profiles.

MeSH terms

  • Animals
  • Anticoagulants / chemistry
  • Anticoagulants / pharmacokinetics
  • Anticoagulants / pharmacology
  • Bridged Bicyclo Compounds, Heterocyclic / chemistry*
  • Bridged Bicyclo Compounds, Heterocyclic / pharmacokinetics
  • Bridged Bicyclo Compounds, Heterocyclic / pharmacology
  • Factor Xa Inhibitors*
  • Hydrophobic and Hydrophilic Interactions
  • Male
  • Models, Molecular
  • Pyrrolidinones / chemistry*
  • Pyrrolidinones / pharmacokinetics
  • Pyrrolidinones / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Serine Proteinase Inhibitors / chemistry*
  • Serine Proteinase Inhibitors / pharmacokinetics
  • Serine Proteinase Inhibitors / pharmacology
  • Stereoisomerism
  • Structure-Activity Relationship

Substances

  • Anticoagulants
  • Bridged Bicyclo Compounds, Heterocyclic
  • Factor Xa Inhibitors
  • Pyrrolidinones
  • Serine Proteinase Inhibitors

Associated data

  • PDB/2VH0